Difference of early response to renal anemia in erythropoiesis-stimulating agents.
Not Applicable
- Conditions
- Chronic kidney disease with renal anemia
- Registration Number
- JPRN-UMIN000017326
- Lead Sponsor
- Shuuwa General Hospital
- Brief Summary
The efficacy of DPO and EPObp were similar and significantly higher than EPO. transferrin saturation (TSAT) was most strongly correlated with delta Hb/EPO dose/kg in all three types of ESAs. Other significant independent factors were Hb, albumin, P, iPTH, and diabetic nephropathy in the EPO group, eGFR in the DPO group, and Fe in the EPObp group. The adjusted coefficient of determination (R2) ranged from 0.415-0.520 in the three ESA groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Patients complicated with potential diseases causing anemia such as hemorrhagic disease, hematological disease, or carcinoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method